{"version":"1.0","provider_name":"Voisins de l'UE","provider_url":"https:\/\/www.eumedbridge.eu\/fr\/","author_name":"Nidhal Battikh","author_url":"https:\/\/www.eumedbridge.eu\/fr\/author\/nidhal_admin\/","title":"Lettre d\u2019information n\u00b03 de SAFEMED IV \u2013 F\u00e9vrier 2020 - Voisins de l'UE","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"KYpw1MDNcJ\"><a href=\"https:\/\/www.eumedbridge.eu\/fr\/publication\/lettre-dinformation-ndeg3-de-safemed-iv-fevrier-2020\/\">Lettre d\u2019information n\u00b03 de SAFEMED IV \u2013 F\u00e9vrier 2020<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.eumedbridge.eu\/fr\/publication\/lettre-dinformation-ndeg3-de-safemed-iv-fevrier-2020\/embed\/#?secret=KYpw1MDNcJ\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0Lettre d\u2019information n\u00b03 de SAFEMED IV \u2013 F\u00e9vrier 2020\u00a0\u00bb &#8212; Voisins de l&#039;UE\" data-secret=\"KYpw1MDNcJ\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.eumedbridge.eu\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/www.eumedbridge.eu\/wp-content\/uploads\/2022\/03\/Capture_11-8.jpg","thumbnail_width":515,"thumbnail_height":727,"description":"Le dernier num\u00e9ro de la lettre d\u2019information de SAFEMED pr\u00e9sente les activit\u00e9s r\u00e9gionales et les actions bilat\u00e9rales du projet financ\u00e9 par l\u2019UE entre Juillet et D\u00e9cembre 2019, ainsi que les principales r\u00e9alisations."}